# contextual query Endothelial (capillary)

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Vascular-associated.  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['ABCB1', 'ATP10A', 'MECOM', 'EPAS1', 'VWF', 'PTPRG', 'MYRIP', 'PTPRB', 'COBLL1', 'ERG']

The provided gene list—**ABCB1, ATP10A, MECOM, EPAS1, VWF, PTPRG, MYRIP, PTPRB, COBLL1,** and **ERG**—is highly indicative of a vascular-associated cell population in the glioblastoma tumour microenvironment. Analysis of these genes reveals key insights into their possible state, properties, and interactions, both in cancer and under physiological conditions:

**Angiogenic Activity and Vascular Identity**
- **VWF (Von Willebrand Factor)** and **ERG** are classic markers of **endothelial cells**. VWF is essential for hemostasis and is exclusively expressed in endothelial cells and megakaryocytes, while ERG is a transcription factor critical for vascular development and maintenance of endothelial cell identity.
- **EPAS1 (HIF2A)** is a hypoxia-inducible factor that regulates genes involved in angiogenesis, notably in response to low oxygen states. Its upregulation suggests adaptation to hypoxia, a frequent feature in both normal and tumoural angiogenic environments.
- **PTPRB** and **PTPRG** are receptor-type protein tyrosine phosphatases expressed in vascular and perivascular cells, modulating signaling that controls vascular stability and endothelial cell function.

**Transport, Barrier Function, and Drug Resistance**
- **ABCB1 (MDR1, P-glycoprotein)** encodes a well-known transporter conferring **multidrug resistance** by exporting xenobiotics and many drugs out of endothelial cells. In the blood-brain barrier, ABCB1 is critical for restricting entry of toxins and pharmaceuticals. Its upregulation in glioblastoma vasculature is associated with chemotherapy resistance and altered barrier integrity.
- **ATP10A** is a phospholipid translocase (P4-ATPase) involved in **membrane asymmetry and vesicle trafficking**, affecting cell polarity and possibly vesicular transport at the blood-brain barrier.

**Plasticity, Differentiation, and Development**
- **MECOM (EVI1)** is a transcriptional regulator engaged in stemness, hematopoiesis, and vascular development. Its re-expression in tumour vasculature suggests a degree of **cellular plasticity** and possibly dedifferentiation or recruitment of stem/progenitor cells to the tumour endothelium.
- **MYRIP** links myosin to Rab27a on vesicles, crucial for regulated exocytosis. In endothelial cells, vesicular trafficking is important for secretion of vasoactive substances and interaction with leukocytes.

**Signaling and Cellular Interactions**
- **COBLL1** modulates cytoskeleton and may influence endothelial cell shape and migration, critical during angiogenesis and vessel remodeling.
- The combination of **protein tyrosine phosphatases (PTPRB, PTPRG)** and transcription factors (**ERG, MECOM, EPAS1**) points to active **signal transduction** underpinning both quiescent and angiogenic endothelial states, as well as **dynamic responses to microenvironmental cues**.

**Metabolic and Oxygenation State**
- **EPAS1** is a sentinel for cellular response to hypoxia, mediating metabolic adaptation and the upregulation of angiogenic factors such as VEGF. High EPAS1 expression may mark adaptation to the hypoxic microenvironment typical of fast-growing tumours, also seen in normal tissues undergoing rapid vascular remodeling.

**Normal and Pathological Interactions**
- In **normal development**, many of these genes guide endothelial differentiation, vessel sprouting, and formation of barrier structures. For instance, **ERG** and **VWF** are induced as endothelial cells mature and form stable vessels.
- In **tumour contexts**, this gene signature is consistent with the so-called “abnormal vasculature” of glioblastoma, which displays **high permeability, aberrant branching, hypoxic signaling**, and resistance to therapies. Similar pathways are co-opted during wound healing, embryogenesis, and inflammation.

> These data suggest the vascular-associated cells are likely **endothelial cells or perivascular cells** manifesting an **active, possibly angiogenic or remodeling phenotype**. They exhibit properties of **barrier regulation, drug resistance, hypoxia adaptation**, and participate in **dynamic interactions** with tumour and immune cells, mirroring both developmental angiogenesis and pathological vessel formation characteristic of glioblastoma.

This signature underscores the cross-talk between tumour cells, endothelial cells, and the surrounding microenvironment—a theme spanning both tumour biology and normal vascular biology. In normal tissues, these genes coordinate **vascular development, barrier function**, and **adaptive responses to tissue demands**; in glioblastoma, their reactivation marks the hijacking and remodeling of these processes to fuel tumour growth and resist therapy.



## References

- [1] MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo. https://www.spandidos-publications.com/10.3892/mmr.2015.4537 None None
- [2] The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.4248 2015-06-04 None
- [3] Human BCAS3 Expression in Embryonic Stem Cells and Vascular Precursors Suggests a Role in Human Embryogenesis and Tumor Angiogenesis https://dx.plos.org/10.1371/journal.pone.0001202 2007-11-21 None
- [4] Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics https://www.frontiersin.org/articles/10.3389/fimmu.2023.1288137/full 2024-01-11 None
- [5] SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia http://biorxiv.org/lookup/doi/10.1101/2021.04.12.438457 2021-04-12 None